David Aaron Lehman - Net Worth and Insider Trading
David Aaron Lehman Net Worth
The estimated net worth of David Aaron Lehman is at least $3 Million dollars as of 2024-11-06. David Aaron Lehman is the GENERAL COUNSEL of Pulmonx Corp and owns about 203,348 shares of Pulmonx Corp (LUNG) stock worth over $1 Million. David Aaron Lehman is the General Counsel of Intersect ENT Inc and owns about 33,747 shares of Intersect ENT Inc (XENT) stock worth over $953,015. David Aaron Lehman is also the SVP and General Counsel of Thoratec Corp and owns about 43,077 shares of Thoratec Corp (THOR) stock worth over $543,201. Details can be seen in David Aaron Lehman's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that David Aaron Lehman has not made any transactions after 2024-09-03 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of David Aaron Lehman
David Aaron Lehman Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, David Aaron Lehman owns 2 companies in total, including Pulmonx Corp (LUNG) , and Intersect ENT Inc (XENT) .
Click here to see the complete history of David Aaron Lehman’s form 4 insider trades.
Insider Ownership Summary of David Aaron Lehman
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| LUNG | Pulmonx Corp | 2024-09-03 | General Counsel |
| XENT | Intersect ENT Inc | 2019-05-06 | General Counsel |
David Aaron Lehman Latest Holdings Summary
David Aaron Lehman currently owns a total of 3 stocks. Among these stocks, David Aaron Lehman owns 203,348 shares of Pulmonx Corp (LUNG) as of September 3, 2024, with a value of $1 Million and a weighting of 49.14%. David Aaron Lehman owns 33,747 shares of Intersect ENT Inc (XENT) as of May 6, 2019, with a value of $953,015 and a weighting of 32.39%. David Aaron Lehman also owns 43,077 shares of Thoratec Corp (THOR) as of October 11, 2013, with a value of $543,201 and a weighting of 18.46%.
Latest Holdings of David Aaron Lehman
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| LUNG | Pulmonx Corp | 2024-09-03 | 203,348 | 7.11 | 1,445,804 |
| XENT | Intersect ENT Inc | 2019-05-06 | 33,747 | 28.24 | 953,015 |
| THOR | Thoratec Corp | 2013-10-11 | 43,077 | 12.61 | 543,201 |
Holding Weightings of David Aaron Lehman
David Aaron Lehman Form 4 Trading Tracker
According to the SEC Form 4 filings, David Aaron Lehman has made a total of 13 transactions in Pulmonx Corp (LUNG) over the past 5 years, including 0 buys and 13 sells. The most-recent trade in Pulmonx Corp is the sale of 5,765 shares on September 3, 2024, which brought David Aaron Lehman around $38,568.
According to the SEC Form 4 filings, David Aaron Lehman has made a total of 0 transactions in Intersect ENT Inc (XENT) over the past 5 years. The most-recent trade in Intersect ENT Inc is the sale of 9,000 shares on May 6, 2019, which brought David Aaron Lehman around $297,180.
According to the SEC Form 4 filings, David Aaron Lehman has made a total of 0 transactions in Thoratec Corp (THOR) over the past 5 years. The most-recent trade in Thoratec Corp is the sale of 21,889 shares on October 11, 2013, which brought David Aaron Lehman around $835,503.
Insider Trading History of David Aaron Lehman
- 1
David Aaron Lehman Trading Performance
David Aaron Lehman Ownership Network
Ownership Network List of David Aaron Lehman
Ownership Network Relation of David Aaron Lehman
David Aaron Lehman Owned Company Details
What does Pulmonx Corp do?
Who are the key executives at Pulmonx Corp?
David Aaron Lehman is the General Counsel of Pulmonx Corp. Other key executives at Pulmonx Corp include director & President and CEO French Glendon E. Iii , Chief Commercial Officer Geoffrey Beran Rose , and Interim CFO John Mckune .
Pulmonx Corp (LUNG) Insider Trades Summary
Over the past 18 months, David Aaron Lehman made 6 insider transaction in Pulmonx Corp (LUNG) with a net sale of 26,948. Other recent insider transactions involving Pulmonx Corp (LUNG) include a net sale of 33,560 shares made by Geoffrey Beran Rose , a net sale of 131,690 shares made by French Glendon E. Iii , and a net sale of 8,441 shares made by Derrick Sung .
In summary, during the past 3 months, insiders sold 50,351 shares of Pulmonx Corp (LUNG) in total and bought 14,245 shares, with a net sale of 36,106 shares. During the past 18 months, 202,659 shares of Pulmonx Corp (LUNG) were sold and 14,245 shares were bought by its insiders, resulting in a net sale of 188,414 shares.
Pulmonx Corp (LUNG)'s detailed insider trading history can be found in Insider Trading Tracker table.
Pulmonx Corp Insider Transactions
David Aaron Lehman Mailing Address
Above is the net worth, insider trading, and ownership report for David Aaron Lehman. You might contact David Aaron Lehman via mailing address: C/o Intersect Ent, Inc., 1555 Adams Drive, Menlo Park Ca 94025.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
